DK0874845T3 - Pyrido[2,3-b]pyrazinderivater - Google Patents
Pyrido[2,3-b]pyrazinderivaterInfo
- Publication number
- DK0874845T3 DK0874845T3 DK96941882T DK96941882T DK0874845T3 DK 0874845 T3 DK0874845 T3 DK 0874845T3 DK 96941882 T DK96941882 T DK 96941882T DK 96941882 T DK96941882 T DK 96941882T DK 0874845 T3 DK0874845 T3 DK 0874845T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkenyl
- pyridyl
- phenyl
- amino
- alkenoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9526558.3A GB9526558D0 (en) | 1995-12-27 | 1995-12-27 | Heterobicyclic derivatives |
PCT/JP1996/003666 WO1997024355A1 (en) | 1995-12-27 | 1996-12-13 | Pyrido (2,3-b) pyrazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0874845T3 true DK0874845T3 (da) | 2002-07-01 |
Family
ID=10786098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96941882T DK0874845T3 (da) | 1995-12-27 | 1996-12-13 | Pyrido[2,3-b]pyrazinderivater |
Country Status (18)
Country | Link |
---|---|
US (1) | US6117875A (da) |
EP (1) | EP0874845B1 (da) |
JP (1) | JP2000502699A (da) |
KR (1) | KR19990072053A (da) |
CN (1) | CN1066732C (da) |
AT (1) | ATE214067T1 (da) |
AU (1) | AU720301B2 (da) |
CA (1) | CA2241690A1 (da) |
DE (1) | DE69619702T2 (da) |
DK (1) | DK0874845T3 (da) |
EA (1) | EA001324B1 (da) |
ES (1) | ES2170286T3 (da) |
GB (1) | GB9526558D0 (da) |
HU (1) | HUP9901038A3 (da) |
IL (1) | IL124673A (da) |
MX (1) | MX9805129A (da) |
PT (1) | PT874845E (da) |
WO (1) | WO1997024355A1 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9413975D0 (en) | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
SK287231B6 (sk) | 1999-08-21 | 2010-04-07 | Nycomed Gmbh | Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora |
WO2001053258A1 (fr) | 2000-01-20 | 2001-07-26 | Eisai Co., Ltd. | Composes azotes cycliques et compositions pharmaceutiques les contenant |
US7098226B2 (en) * | 2000-05-31 | 2006-08-29 | Santen Pharmaceutical Co., Ltd. | TNF-α production inhibitors |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
WO2004041819A1 (ja) * | 2002-11-06 | 2004-05-21 | Grelan Pharmaceutical Co., Ltd. | ピラゾロナフチリジン誘導体 |
US7504401B2 (en) * | 2003-08-29 | 2009-03-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
EP1729771B1 (en) | 2004-03-22 | 2009-10-14 | Eli Lilly & Company | Pyridyl derivatives and their use as mglu5 receptor antagonists |
CA2603830A1 (en) * | 2005-05-24 | 2006-11-30 | Pharmacia & Upjohn Co Llc | PYRIDINE [2,3-B] PYRAZINONES |
US20080280891A1 (en) * | 2006-06-27 | 2008-11-13 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
US8178556B2 (en) * | 2008-03-05 | 2012-05-15 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
US8551996B2 (en) * | 2009-02-20 | 2013-10-08 | Emory University | Compounds, compositions, methods of synthesis, and methods of treatment |
CN101875627B (zh) * | 2009-04-30 | 2014-01-15 | 凯惠科技发展(上海)有限公司 | 一种1-烷氧羰基-2h-异吲哚衍生物及其制备方法和中间体 |
JP2022532178A (ja) * | 2019-05-10 | 2022-07-13 | 上海海雁医薬科技有限公司 | 置換フェニルプロペニルピリジン誘導体、その調製方法及びその医学的使用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0008864A1 (en) * | 1978-08-15 | 1980-03-19 | FISONS plc | Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them |
GB9413975D0 (en) * | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
-
1995
- 1995-12-27 GB GBGB9526558.3A patent/GB9526558D0/en active Pending
-
1996
- 1996-12-13 CN CN96199282A patent/CN1066732C/zh not_active Expired - Fee Related
- 1996-12-13 WO PCT/JP1996/003666 patent/WO1997024355A1/en not_active Application Discontinuation
- 1996-12-13 DE DE69619702T patent/DE69619702T2/de not_active Expired - Fee Related
- 1996-12-13 ES ES96941882T patent/ES2170286T3/es not_active Expired - Lifetime
- 1996-12-13 KR KR1019980704348A patent/KR19990072053A/ko not_active Application Discontinuation
- 1996-12-13 DK DK96941882T patent/DK0874845T3/da active
- 1996-12-13 CA CA002241690A patent/CA2241690A1/en not_active Abandoned
- 1996-12-13 EA EA199800599A patent/EA001324B1/ru not_active IP Right Cessation
- 1996-12-13 IL IL12467396A patent/IL124673A/en not_active IP Right Cessation
- 1996-12-13 AT AT96941882T patent/ATE214067T1/de not_active IP Right Cessation
- 1996-12-13 JP JP9524170A patent/JP2000502699A/ja active Pending
- 1996-12-13 PT PT96941882T patent/PT874845E/pt unknown
- 1996-12-13 HU HU9901038A patent/HUP9901038A3/hu unknown
- 1996-12-13 AU AU11112/97A patent/AU720301B2/en not_active Ceased
- 1996-12-13 EP EP96941882A patent/EP0874845B1/en not_active Expired - Lifetime
- 1996-12-13 US US09/091,361 patent/US6117875A/en not_active Expired - Fee Related
-
1998
- 1998-06-24 MX MX9805129A patent/MX9805129A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2170286T3 (es) | 2002-08-01 |
US6117875A (en) | 2000-09-12 |
DE69619702D1 (de) | 2002-04-11 |
EP0874845B1 (en) | 2002-03-06 |
GB9526558D0 (en) | 1996-02-28 |
AU1111297A (en) | 1997-07-28 |
WO1997024355A1 (en) | 1997-07-10 |
IL124673A (en) | 2002-07-25 |
CN1066732C (zh) | 2001-06-06 |
CN1205702A (zh) | 1999-01-20 |
AU720301B2 (en) | 2000-05-25 |
KR19990072053A (ko) | 1999-09-27 |
MX9805129A (es) | 1998-10-31 |
EA001324B1 (ru) | 2001-02-26 |
PT874845E (pt) | 2002-08-30 |
CA2241690A1 (en) | 1997-07-10 |
ATE214067T1 (de) | 2002-03-15 |
IL124673A0 (en) | 1998-12-06 |
DE69619702T2 (de) | 2002-08-14 |
EA199800599A1 (ru) | 1998-12-24 |
HUP9901038A3 (en) | 2000-04-28 |
JP2000502699A (ja) | 2000-03-07 |
EP0874845A1 (en) | 1998-11-04 |
HUP9901038A2 (hu) | 1999-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69619702D1 (de) | Pyrido (2,3-b) pyrazinderivate | |
AU4954097A (en) | 2-pyrimidineamine derivatives and processes for their preparation | |
AU7453498A (en) | Sulfonamide derivatives, their production and use | |
GR3034542T3 (en) | 4,5-diaryloxazole derivatives | |
ATE195117T1 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
BG103195A (en) | Substituted indazole derivatives and their application as inhibitors of phosphodiesterase (pde) type iv and of the production of a tumournecrotic factor (tnf) | |
AU4064597A (en) | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof | |
CA2176935A1 (fr) | Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d | |
EP1140900A4 (en) | PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS | |
AU1556997A (en) | Chinoline and benzimidazole derivatives as bradykinin agonists | |
FI951555A0 (fi) | 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet | |
NZ332310A (en) | Optionally condensed pyrimidine substituted hexahydro-pyrido[4,3-b]indole derivatives and medicaments | |
EP1110960A4 (en) | AGENTS INDUCING APOPTOSIS | |
DE69613385D1 (de) | Cephemverbindungen | |
NO953913D0 (no) | Perhydroisoindolderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene |